Advanced treatments most countries can't offer yet — reached in one trip.
Cancer, rare-disease and cell therapies at China's Boao Lecheng zone. NF MediPath handles everything — starting with a free availability check.
Free assessment · Reply within 24 hours · No obligation
518
Approved drugs & devices
30
Advanced cell & gene therapies
36
Operating hospitals
190k+
Patients treated
Why Lecheng — two pathways
518
Global medicines & devices
Overseas-approved, available here first. The cancer, eye and rare-disease treatments you'd otherwise fly to the US or Europe for, through one coordinated trip.
30
Advanced cell & gene therapy
Regenerative therapies with published prices. Stem-cell, NK/DC cancer vaccines and gene therapy — restricted or unavailable in most Western countries — delivered by top-tier hospitals at a price you can see upfront.
What we help you access — by condition
Pick your condition — we'll check availability and match you to the right hospital, free.
Why go through NF MediPath
We tell you upfront whether your treatment is actually available — before you spend a yuan on travel.
- Availability check first — we confirm whether your treatment is offered before you plan anything.
- Right-hospital match among 36 hospitals (Ruijin Hainan, West China and more).
- Visa & travel — invitation letters, routing and timing handled.
- Interpreter & stay — bilingual coordination on the ground.
- Follow-up & remote refills after you return home.
- Clear, all-in cost — no surprises.
How it works
01
Submit inquiry
Tell us the condition and share any reports. Free and confidential.
02
We check availability
Our team confirms whether the treatment is offered at Lecheng and matches a hospital.
03
Travel & treatment
Visa, routing, interpreter and stay coordinated end to end.
04
Meds & follow-up
Take-home supply where permitted, plus remote follow-up after you return.
Transparent pricing
Government-filed, published prices — so you can plan before you travel. A few examples:
Bone & Joint
from ¥36,000 / session
≈ US$5,000
Oncology
from ¥150,000 / dose
≈ US$20,600
Rare / Eye
¥480,000 / eye
≈ US$66,000
30 therapies across 10 specialties. USD approximate; rates vary. Cell therapies are self-pay. Imported drugs may be partly covered by Lecheng Global Specialty Drug Insurance (from ¥29/yr).
Availability and pricing are confirmed per-patient and change over time. Verify the current list at lczxyf.com.
A regulated pathway — not a loophole.
Government-licensed
China's first real-world-data pilot zone; 20+ products have graduated from Lecheng to the national market.
Filed, public pricing
Prices are jointly filed by the Lecheng Administration and the insurance bureau — published, not negotiated per patient.
Top-tier hospitals
Ruijin, West China and Shulan deliver treatment directly, within an established clinical system.
Backed by NF MediPath and United Family Healthcare. Explore our network hospitals, specialists and patient stories.
Frequently asked questions
Request your free assessment
Free · We reply within 24 hours · Your information is kept confidential.
NF MediPath is an independent patient-facilitation service — we coordinate access and logistics; we are not a medical provider and do not provide treatment or medical advice. The list of licensed drugs, devices and approved biomedical technologies in the Boao Lecheng zone, and their prices, change over time. Availability and pricing of any specific treatment are confirmed on a per-patient basis. Treatment listing current as of May 2026; drug/device totals as of Sept 2025. Prices are in RMB, government-filed and subject to change; USD figures approximate. Verify the current list at lczxyf.com.